{"id":17868,"date":"2024-03-30T16:13:45","date_gmt":"2024-03-30T21:13:45","guid":{"rendered":"https:\/\/autism.org\/?p=17868"},"modified":"2024-09-23T15:39:35","modified_gmt":"2024-09-23T20:39:35","slug":"biomarkers-and-pathophysiology","status":"publish","type":"post","link":"https:\/\/autism.org\/biomarkers-and-pathophysiology\/","title":{"rendered":"Biomarkers start telling us a story: Autism pathophysiology revisited"},"content":{"rendered":"

<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div>
<\/div>
<\/div>
<\/div>
\"World<\/span><\/div><\/div>
<\/div>
<\/div>
<\/div>

This is a joint presentation with the World Autism Organisation.<\/strong><\/p>\n<\/div>

Antonio Persico, MD<\/a>, a recent ARI Research Grant recipient<\/a>, explores the role of biomarkers in understanding autism pathophysiology. He discusses the complexity inherent to neurodevelopmental conditions and emphasizes the need to combine information from multiple fields of investigation. The presenter discusses contemporary autism research on genomics, methylomics, transcriptomics, proteomics, metabolomics, and functional brain imaging. He highlights the implications of protein transcription regulation and how it appears across groups and generations. Persico reiterates the complexities of neurodevelopmental conditions and the need for interdisciplinary research and understanding before the Q&A. <\/span><\/p>\n

This is a joint presentation with the World Autism Organisation.<\/p>\n<\/div>

<\/div>
<\/div>
<\/div>